CoChat

HDAC 2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease

Open access
Mahady, L., Nadeem, M., Malek‐Ahmadi, M., Chen, K., Perez, S. E., Mufson, E. J. · 2019 · Neuropathology and Applied Neurobiology
Cited by 63

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Aims: Alzheimer's disease (AD) is characterized by degeneration of cholinergic basal forebrain (CBF) neurons in the nucleus basalis of Meynert (nbM), which provides the major cholinergic input to the cortical mantle and is related to cognitive decline in patients with AD. Cortical histone deacetylase (HDAC) dysregulation has been associated with neuronal degeneration during AD progression. However, whether HDAC alterations play a role in CBF degeneration during AD onset is unknown. We investigated global HDAC protein levels and nuclear HDAC2 immunoreactivity in tissue containing the nbM, changes and their association with neurofibrillary tangles (NFTs) during the progression of AD. Methods: We used semi‐quantitative western blotting and immunohistochemistry to evaluate HDAC and sirtuin (SIRT) levels in individuals that died with a premortem clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment (MCI), mild/moderate AD (mAD) or severe AD (sAD). Quantitative immunohistochemistry was used to identify HDAC 2 protein levels in individual cholinergic nbM nuclei and their colocalization with the early phosphorylated tau marker AT 8, the late‐stage apoptotic tau marker TauC3 and Thioflavin‐S, a marker of β‐pleated sheet structures in NFT s. Results: In AD patients, HDAC 2 protein levels were dysregulated in the basal forebrain region containing cholinergic neurons of the nbM. HDAC 2 nuclear immunoreactivity was reduced in individual cholinergic nbM neurons across disease stages. HDAC 2 nuclear reactivity correlated with multiple cognitive domains and with NFT formation. Conclusions: These findings suggest that HDAC 2 dysregulation contributes to cholinergic nbM neuronal dysfunction, NFT pathology, and cognitive decline during clinical progression of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nan.12518

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 63

Metadata

Authors
Mahady, L., Nadeem, M., Malek‐Ahmadi, M., Chen, K., Perez, S. E., & Mufson, E. J.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2018-10-28
Volume
45
Issue
4
Pages
380-397
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W2892577031
Cited by
63
References
19
FWCI
2.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HDAC 2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease. https://app.cochat.ai/papers/10.1111/nan.12518
The paper
Mahady, L., Nadeem, M., Malek‐Ahmadi, M., Chen, K., Perez, S. E., & Mufson, E. J. (2019). HDAC 2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12518

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.